TRIMETHOPRIM - search results

United States - English - NLM (National Library of Medicine)

trimethoprim tablet

teva pharmaceuticals usa, inc. - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x) - trimethoprim 100 mg

United States - English - NLM (National Library of Medicine)

primsol- trimethoprim hydrochloride solution

fsc laboratories, inc - trimethoprim hydrochloride (unii: 9xe000ou9b) (trimethoprim - unii:an164j8y0x) - trimethoprim 50 mg in 5 ml - primsol solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. for the treatment of acute otitis media due to susceptible strains of streptococcus pneumoniae and haemophilus influenzae. note: moraxella catarrhalis isolates were found consistently resistant to trimethoprim in vitro. therefore, when infection with moraxella catarrhalis is suspected, the use of alternative antimicrobial agents should be considered. primsol is not indicated for prophylactic or prolonged administration in otitis media at any age. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli, proteus mirabilis, klebsiella pneumoniae, enterobacter species and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and susceptibility tests should be performed to determine the susceptibility of the bacteria to trimethoprim

United States - English - NLM (National Library of Medicine)

polymyxin b sulfate and trimethoprim solution

akorn - trimethoprim sulfate (unii: e377mf8eq8) (trimethoprim - unii:an164j8y0x), polymyxin b sulfate (unii: 19371312d4) (polymyxin b - unii:j2vz07j96k) - trimethoprim 1 mg in 1 ml - polymyxin b sulfate and trimethoprim ophthalmic solution is indicated in the treatment of surface ocular bacterial infections, including acute bacterial conjunctivitis, and blepharoconjunctivitis, caused by susceptible strains of the following microorganisms: staphylococcus aureus, staphylococcus epidermidis, streptococcus pneumoniae, streptococcus viridans, haemophilus influenza and pseudomonas aeruginosa. * *efficacy for this organism in this organ system was studied in fewer than 10 infections. polymyxin b sulfate and trimethoprim ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

United States - English - NLM (National Library of Medicine)

primsol- trimethoprim hydrochloride solution

allegis holdings, llc - trimethoprim hydrochloride (unii: 9xe000ou9b) (trimethoprim - unii:an164j8y0x) - trimethoprim 50 mg in 5 ml - primsol solution is indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the conditions listed below. for the treatment of acute otitis media due to susceptible strains of streptococcus pneumoniae and haemophilus influenzae . note: moraxella catarrhalis isolates were found consistently resistant to trimethoprim in vitro . therefore, when infection with moraxella catarrhalis is suspected, the use of alternative antimicrobial agents should be considered. primsol is not indicated for prophylactic or prolonged administration in otitis media at any age. for the treatment of initial episodes of uncomplicated urinary tract infections due to susceptible strains of the following organisms: escherichia coli, proteus mirabilis, klebsiella pneumoniae, enterobacter species and coagulase-negative staphylococcus species, including s. saprophyticus . cultures and s